UNSPSC 51382102: Carprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H12ClNO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FFL0D546HO, chemically known as 9h-carbazole-2-acetic acid, 6-chloro-alpha-methyl- but generally known as carprofen, which bears US NIH Compound Identifier 2581. European Medicines Agency schedules Carprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06144MIG.

UNSPSC 51382102 Carprofen is a Commodity code that nominally covers a nonsteroidal anti-inflammatory veterinary pharmaceutical, but recent state and local procurement activity under this code shows a significant mismatch with the code's stated scope. The single recent opportunity on record—Seminole County, Florida's IFB60459723LAS, posted June 30, 2026—solicits Naloxone and Safe Drug Deactivation Systems for community health initiatives, not carprofen. Naloxone is an opioid antagonist used in overdose response; Drug Deactivation Systems are medical waste or pharmacy decontamination equipment. Neither product aligns with carprofen's veterinary anti-inflammatory indication or pharmaceutical classification. This code shows little relevant recent activity for the commodity it nominally describes.

Seminole County's procurement sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB included a July 26, 2023 response deadline (note: the posted date of June 30, 2026 appears inconsistent with the July 2023 deadline, suggesting a data error in the source record). Vendors were required to include all shipping and delivery costs in their proposals, comply with drug-free workplace and E-Verify requirements, and maintain specified insurance coverages. The contract structure offered an initial two-year term with a one-year renewal option and included a three-month probationary termination period. The procurement did not designate explicit set-asides for disadvantaged enterprises and was potentially FEMA-funded, introducing federal compliance obligations including the Clean Air Act and Federal Water Pollution Control Act. Business development professionals should verify whether this code assignment reflects a taxonomy misclassification or intentional categorization before allocating pursuit resources to carprofen-related opportunities under this code.